From March 20 to March 23, the Austrian capital Vienna hosted the 16th St. Gallen International Breast Cancer Conference. After three days of presentations that reviewed the recent developments in the primary treatment of early breast cancer, the meeting culminated in the traditional consensus session on the fourth day of the conference. In this session, a panel of 53 experts was asked to cast their vote on more than 135 (detailed) questions on the treatment of early breast cancer.
Established in 1978 in the Swiss town of St. Gallen, the St. Gallen International Breast Cancer Conference is now biannually organised in Vienna. This meeting is a global, multidisciplinary conference with over 2,000 representatives from multiple nations and every continent. The conference offers educational presentations that review recent developments in several areas of early breast cancer treatment. The highlight of the conference is the consensus panel meeting. This year, i...
please login to read the entire article:
You need to register to read the entire article, please do so now.
Table of Contents: BCC 2019
St. Gallen Consensus
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.